Display:
2016
|
Year
|
Title
|
Authors
|
Publication
|
|
2016
|
Corrigendum to “Diversity in exon 5 of HLA-C*04:01:01G is significant in anthropological studies” [Hum. Immunol. 77 (2016) 426–428].
|
Dunn PPJ, Lamb G, Selwyn C, Compton J, Yang E, Maiers M, Fernandez-Vina M
|
Hum Immunol 77(10):1004
|
|
2016
|
The Blood and Marrow Transplant Clinical Trials Network: an effective infrastructure for addressing important issues in hematopoietic cell transplantation: Steering committee of the Blood and Marrow Transplant Clinical Trials Network.
|
Horowitz MM
|
Biol Blood Marrow Transplant 22(10):1747-1757
|
|
2016
|
Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis.
|
Deol A, Sengsayadeth S, Ahn KW, Wang H-L, Aljurf M, Antin JH, Battiwalla M, Bornhauser M, Cahn J-Y, Camitta B, Chen Y-B, Cutler CS, Gale RP, Ganguly S, Hamadani M, Inamoto Y, Jagasia M, Kamble R, Koreth J, Lazarus HM, Liesveld J, Litzow MR, Marks DI, Nishihori T, Olsson RF, Reshef R, Rowe JM, Saad AA, Sabloff M, Schouten HC, Shea TC, Soiffer RJ, Uy GL, Waller EK, Wiernik PH, Wirk B, Woolfrey AE, Bunjes D, Devine S, de Lima M, Sandmaier BM, Weisdorf D, Khoury HJ, Saber W
|
Cancer 122(19):3005-3014
|
|
2016
|
Methods for generating paired competing risks data.
|
Brazauskas R, Le-Rademacher J
|
Comput Methods Programs Biomed
|
|
2016
|
A BMT CTN phase II trial of unrelated donor marrow transplantation for children with severe sickle cell disease.
|
Shenoy S, Eapen M, Panepinto, JA, Logan BR, Wu J, Abraham, A, Brochstein, J, Chaudhury, S, Godder, K, Haight AE, Kasow, KA, Leung, K, Andreansky, M, Bhatia, M, Dalal, J, Haines, H, Jaroscak, J, Lazarus, H, Levine, JE, Krishnamurti, L, Margolis, D, Megason, GC, Yu LC, Pulsipher, MA, Gersten, I, Difronzo N, Horowitz, M, Walters, MC, Kamani, N
|
Blood
|
|
2016
|
Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched sibling donors.
|
Ghosh N, Karmali R, Rocha V, Ahn KW, DiGilio A, Hari PN, Bachanova V, Bacher U, Dahi P, de Lima M, D'Souza A, Fenske TS, Ganguly S, Kharfan-Dabaja MA, Prestidge TD, Savani BN, Smith SM, Sureda A, Waller EK, Jaglowski S, Herrera AF, Armand P, Salit RB, Wagner-Johnston ND, Fuchs E, Bolaños-Meade J, Hamadani M
|
J Clin Oncol 34(26):3141-3149
|
|
2016
|
How transplant centers deal with the dextran shortage: Recommendations for comparing alternatives.
|
Brady C, Armitage S, Freed B, Duffy M, Gass A, Spellman S, Kurtzverg J, Regan D
|
Transfusion
|
|
2016
|
Novel HLA-DP region susceptibility loci associated with severe acute GvHD.
|
Goyal RK, Lee SJ, Wang T, Trucco M, Haagenson M, Spellman SR, Veneris M, Ferrell RE
|
Bone Marrow Transplant
|
|
2016
|
Donor KIR B genotype improves progression-free survival of non-Hodgkin lymphoma patients receiving unrelated donor transplantation.
|
Bachanova V, Weisdorf DJ, Wang T, Marsh SGE, Trachtenberg E, Haagenson MD, Spellman SR, Ladner M, Guethlein LA, Parham P, Miller JS, Cooley SA
|
Biol Blood Marrow Transplant 22(9):1602-1607
|
|
2016
|
Infection rates among acute leukemia patients receiving alternative donor hematopoietic cell transplantation.
|
Ballen K, Ahn KW, Chen M, Abdel-Azim H, Ahmed I, Aljurf M, Antin J, Bhatt AS, Boeckh M, Chen G, Dandoy C, George B, Laughlin M, Lazarus HM, MacMillan ML, Margolis DA, Marks DI, Norkin M, Rosenthal J, Saad A, Savani B, Schouten HC, Storek J, Szabolcs P, Ustun C, Verneris MR, Waller EK, Weisdorf DJ, Williams KM, Wingard JR, Wirk B, Wolfs T, Young JH, Auletta J, Komanduri KV, Lindemans C, Riches ML
|
Biol Blood Marrow Transplant 22(9):1063-1645
|
|
2016
|
Autologous transplant remains the preferred therapy for relapsed APL in CR2.
|
Ganzel C, Mathews V, Alimoghaddam K, Ghavamzadeh A, Kuk D, Devlin S, Wang H, Zhang M-J, Weisdorf D, Douer D, Rowe JM, Polge E, Esteve J, Nagler A, Mohty M, Tallman M
|
Bone Marrow Transplant 51(9):1180-1183
|
|
2016
|
Allogeneic hematopoietic cell transplantation as curative therapy for patients with non-Hodgkin lymphoma: increasingly successful application to older patients.
|
Fenske TS, Hamadani M, Cohen JB, Costa LJ, Kahl BS, Evens AM, Hamlin PA, Lazarus HM, Petersdorf E, Bredeson C
|
Biol Blood Marrow Transplant 22(9):1543-1551
|
|
2016
|
Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot study
|
Denzen EM, Thao V, Hahn T, Lee SJ, McCarthy PL, Rizzo JD, Ammi M, Drexler R, Flesch S, James H, Omondi N, Murphy E, Pederson K, Majhail NS
|
Bone Marrow Transplant 51(9):1233-1240
|
|
2016
|
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus recommendations for research methodology and study design.
|
Shaw BE, Hahn T, Martin PJ, Mitchell S, Petersdorf EW, Armstrong GT, Shelburne N, Storer B, Bhatia S
|
Biol Blood Marrow Transplant
|
|
2016
|
What is the (p-) value of the P-value?
|
Gale RP, Hochhaus A, Zhang M-J
|
Leukemia
|
|
2016
|
Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the (BMT CTN) 0803/(AMC) 071 trial.
|
Alvarnas JC, Rademacher JL, Wang Y, Akpek G, Ayala E, Devine S, Baiocchi R, Lozanski G, Kaplan L, Noy A, Popat U, Hsu J, Morris LE Jr, Thompson J, Horowitz MH, Mendizabal A, Levine A, Krishnan A, Forman SJ, Navarro, WH, Ambinder R
|
Blood 128(8):1050-1058
|
|
2016
|
Patient-reported outcomes and socioeconomic status as predictors of clinical outcomes following hematopoietic stem cell transplantation: A study from the BMT CTN 0902 trial.
|
Knight JM, Syrjala KL, Majhail NS, Martens M, Le-Rademacher J, Logan BR, Lee SJ, Jacobsen PB, Wood WA, Jim HSL, Wingard JR, Horowitz MM, Abidi MH, Fei M, Rawls L, Rizzo JD
|
Biol Blood Marrow Transplant
|
|
2016
|
Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT.
|
DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL, Arat M, Baker KS, Burns LJ, Duncan CN, Gilleece M, Hale GA, Hamadani M, Hamilton BK, Hogan WJ, Hsu JW, Inamoto Y, Kamble RT, Lupo-Stanghellini MT, Malone AK, McCarthy P, Mohty M, Norkin M, Paplham P, Ramanathan M, Richart JM, Salooja N, Schouten HC, Schoemans H, Seber A, Steinberg A, Wirk BM, Wood WA, Battiwalla M, Flowers MED, Savani BN, Shaw BE
|
Bone Marrow Transplant
|
|
2016
|
Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis.
|
O'Donnell PV, Eapen M, Horowitz MM, Logan BR, DiGilio A, Brunstein C, Fuchs E, Flowers MED, Salit R, Raj K, Pagliuca A, Bradstock K, Granata A, Castagna L, Fürst S, Blaise D
|
Bone Marrow Transplant
|
|
2016
|
Trajectories of quality of life after hematopoietic cell transplantation: Secondary analysis of BMT CTN 0902 data.
|
Jim HSL, Sutton SK, Small BJ, Jacobsen PB, Wood WA, Knight J, Majhail NS, Syrjala KL, Lee SJ
|
Biol Blood Marrow Transplant
|
|
2016
|
Comparison of patient-reported outcomes in 5-year survivors who received gone marrow vs peripheral blood unrelated donor transplantation: long-term follow-up of a randomized clinical trial.
|
Lee SJ, Logan B, Westervelt P, Cutler C, Woolfrey A, Khan SP, Waller EK, Maziarz RT, Wu J, Shaw BE, Confer D, Horowitz MM, Anasetti C
|
JAMA Oncol
|
|
2016
|
Health-related quality of life among pediatric hematopoietic stem cell donors.
|
Switzer GE, Bruce J, Kiefer DM, Kobusingye H, Drexler R, Besser RM, Confer DL, Horowitz MM, King RL, Shaw BE, van Walraven SM, Weiner L, Packman W, Varni JW, Pulsipher MA
|
J Pediatr
|
|
2016
|
Post-transplant outcomes in high-risk compared to non-high risk multiple myeloma, a CIBMTR analysis.
|
Scott EC, Hari P, Sharma M, Le-Rademacher J, Huang J, Vogl D, Abidi M, Beitinjaneh A, Fung H, Ganguly S, Hildebrandt G, Holmberg L, Kalaycio M, Kumar S, Kyle R, Lazarus H, Lee C, Maziarz RT, Meehan K, Mikhael J, Nishihori T, Ramanathan M, Usmani S, Tay J, Vesole D, Wirk B, Yared J, Savani BN, Gasparetto C, Krishnan A, Mark T, Nieto Y, D'Souza A
|
Biol Blood Marrow Transplant
|
|
2016
|
Haplogic: a predictive HLA matching algorithm to enhance rapid identification of the optimal unrelated hematopoietic stem cell sources for transplant.
|
Dehn J, Setterholm M, Buck K, Kempenich J, Beduhn B, Gragert L, Madbouly A, Fingerson S, Maiers M
|
Biol Blood Marrow Transplant
|
|
2016
|
The impact of palifermin use on hematopoietic cell transplant outcomes in children.
|
Saber W, Zhang M-J, Steinert P, Chen M, Horowitz MM
|
Biol Blood Marrow Transplant 22(8):1460-1466
|
|
2016
|
Reduced-intensity conditioning with fludarabine, cyclophosphamide, and high-dose rituximab for allogeneic hematopoietic cell transplantation for follicular lymphoma: a phase two multicenter trial from the Blood and Marrow Transplant Clinical Trials Network.
|
Laport GG, Wu J, Logan B, Bachanova V, Hosing C, Fenske T, Longo W, Devine SM, Nademanee A, Gersten I, Horowitz M, Lazarus HM, Riches ML
|
Biol Blood Marrow Transplant 22(8):1440-1448
|
|
2016
|
Immune-mediated complications after hematopoietic stem cell transplantation.
|
Li Z, Rubinstein SM, Thota R, Savani M, Brissot E, Shaw BE, Majhail NS, Mohty M, Savani BN
|
Biol Blood Marrow Transplant 22(8):1368-1375
|
|
2016
|
Voriconazole pharmacokinetics following HSCT: results from the BMT CTN
0101 trial.
|
Hope WW, Walsh TJ, Goodwin J, Peloquin CA, Howard A, Kurtzberg J, Mendizabal A, Confer DL, Bulitta J, Baden LR, Neely MN, Wingard JR
|
J Antimicrob Chemother 71(8):2234-2240
|
|
2016
|
Intravenous busulfan-based myeloablative conditioning regimens prior to hematopoietic cell transplantation for hematologic malignancies.
|
Pasquini MC, Le-Rademacher J, Zhu X, Artz A, DiPersio J, Fernandez HF, Mineishi S, Kamishohara M, Mehta J, Nakamura Y, Ratanatharathorn V, Sobecks R, Burkart J, Bredeson C
|
Biol Blood Marrow Transplant 22(8):1424-1430
|
|
2016
|
Validation study failed to confirm an association between genetic variants in the base excision repair pathway and transplant-related mortality and relapse after hematopoietic cell transplantation.
|
Arora M, Lee SJ, Spellman SR, Weisdorf DJ, Guan W, Haagenson M, Wang T, Horowitz MH, Verneris MR, Fleischhauer K, Hsu K, Thyagarajan B
|
Biol Blood Marrow Transplant 22(8):1531-1532
|
|
2016
|
Consensus opinion on allogeneic hematopoietic cell transplantation in advanced systemic mastocytosis.
|
Ustun C, Gotlib J, Popat U, Artz A, Litzow M, Reiter A, Nakamura R, Kluin-Nelemans HC, Verstovsek S, Gajewski J, Perales M-A, George T, Shore T, Sperr W, Saber W, Kota V, Yavuz AS, Pullarkat V, Rogosheske J, Hogan W, Van Besien K, Hagglund H, Damaj G, Arock M, Horny H-P, Metcalfe DD, Deeg HJ, Devine S, Weisdorf D, Akin C, Valent P
|
Biol Blood Marrow Transplant 22(8):1348-1356
|
|
2016
|
Impact of early CMV reactivation in cord blood stem cell recipients in the current era.
|
Ramanathan M, Teira P, Battiwalla M, Barrett J, Ahn KW, Chen M, Green J, Laughlin M, Lazarus HM, Marks D, Saad A, Seftel M, Saber W, Savani B, Waller EK, Wingard J, Auletta JJ, Lindemans CA, Boeckh M, Riches ML
|
Bone Marrow Transplant 51(8):1113-1120
|
|
2016
|
Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft.
|
Epperla N, Pasquini M, Pierce K, Droybyski WR, Rizzo JD, Horowitz MM, Saber W, Zellner K, Ramirez S, Bartz K, Raj RV, Hari PN, Hamadani M
|
Bone Marrow Transplant
|
|
2016
|
Metabolic syndrome and cardiovascular disease after hematopoietic cell transplantation: screening and preventive practice recommendations from the CIBMTR and EBMT.
|
DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL, Arat M, Baker KS, Burns LJ, Duncan CN, Gilleece M, Hale GA, Hamadani M, Hamilton BK, Hogan WJ, Hsu JW, Inamoto Y, Kamble RT, Lupo-Stanghellini MT, Malone AK, McCarthy P, Mohty M, Norkin M, Paplham P, Ramanathan M, Richart JM, Salooja N, Schouten HC, Schoemans H, Seber A, Steinberg A, Wirk BM, Wood WA, Battiwalla M, Flowers MED, Savani BN, Shaw BE
|
Biol Blood Marrow Transplant 22(8):1493-1503
|
|
2016
|
Busulfan, melphalan, and bortezomib versus high-dose melphalan as a conditioning regimen for autologous hematopoietic stem cell transplantation in multiple myeloma.
|
Rodriguez TE, Hari P, Stiff PJ, Smith SE, Sterrenberg D, Vesole D
|
Biol Blood Marrow Transplant 22(8):1391-1396
|
|
2016
|
HLA polymorphism and risk of multiple myeloma.
|
Beksac M, Gragert L, Fingerson S, Maiers M, Zhang M-J, Albrecht M, Zhong X, Cozen W, Dispenzieri A, Lonial S, Hari P
|
Leukemia
|
|
2016
|
A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation.
|
Magenau J, Westervelt P, Khaled S, McGuirk J, Hari P, Eapen M, Becker PS, Parkin B, Braun T, Logan B, Wang H, Jagasia M, Rowley SD, Kim DD, Schechter T, Frey N, Scott B, Churay T, Lieland S, Forman S, Mineishi S
|
Bone Marrow Transplant
|
|
2016
|
YKL-40 in allogeneic hematopoietic cell transplantation after AML and myelodysplastic syndrome.
|
Kornblit B, Wang T, Lee SJ, Spellman SR, Zhu X, Fleischhauer K, Müller C, Johansen JS, Vindelov L, Garred P
|
Bone Marrow Transplant
|
|
2016
|
Analysis of variance components for genetic markers with unphased genotypes.
|
Wang T
|
Front Genet 7(123):1-12
|
|
2016
|
What is the P-value anyway?
|
Gale RP, Zhang M-J
|
Bone Marrow Transplant
|
|
2016
|
Haematopoietic cell transplants in Latin America.
|
Gale RP, Seber A, Bonfim C, Pasquini M
|
Bone Marrow Transplant 51(7):898-905
|
|
2016
|
Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation.
|
Fenske TS, Ahn KW, Graff TM, DiGilio A, Bashir Q, Kamble RT, Ayala E, Bacher U, Brammer JE, Cairo M, Chen A, Chen Y-B, Chhabra S, D'Souza A, Farooq U, Freytes C, Ganguly S, Hertzberg M, Inwards D, Jaglowski S, Kharfan-Dabaja MA, Lazarus HM, Nathan S, Pawarode A, Perales M-A, Reddy N, Seo S, Sureda A, Smith SM, Hamadani M
|
Br J Haematol 174(2):235-248
|
|
2016
|
Defibrotide for Treatment of Severe Veno-Occlusive Disease in Pediatrics and Adults: An Exploratory Analysis Using Data from the CIBMTR.
|
Strouse C, Richardson P, Prentice G, Korman S, Hume R, Nejadnik B, Horowitz MM, Saber W
|
Biol Blood Marrow Transplant 22(7):1306-1312
|
|
2016
|
Allogeneic hematopoietic cell transplantation in multiple myeloma: impact of disease risk and post allograft minimal residual disease on survival.
|
Dhakal B, D'Souza A, Martens M, Kapke J, Harrington AM, Pasquini M, Saber W, Drobyski WR, Zhang M-J, Hamadani M, Hari PN
|
Clin Lymphoma Myeloma Leuk 16(7):379-386
|
|
2016
|
The limitations of qPCR telomere length measurement in diagnosing dyskeratosis congenita.
|
Gadalla SM, Khincha PP, Katki HA, Giri N, Wong JYY, Spellman S, Yanovski JA, Han JC, De Vivo, Alter BP, Savage SA
|
Mol Genet Genomic Med 4(4):475-479
|
|
2016
|
Efficacy of pharmacokinetics-directed busulfan, cyclophosphamide and etoposide conditioning and autologous stem cell transplantation for lymphoma: comparison of a multicenter phase 2 study and CIBMTR outcomes.
|
Flowers CR, Costa LJ, Pasquini MC, Le-Rademacher J, Lill M, Shore TB, Vaughan W, Craig M, Freytes CO, Shea TC, Horwitz ME, Fay JW, Mineishi S, Rondelli D, Mason J, Braunschweig I, Ai W, Yeh RF, Rodriguez TE, Flinn I, Comeau T, Yeager AM, Pulsipher MA, Bence-Bruckler I, Laneuville P, Bierman P, Chen AI, Kato K, Wang Y, Xu C, Smith AJ, Waller EK
|
Biol Blood Marrow Transplant 22(7):1197-1205
|
|
2016
|
Charting improvements in US registry HLA typing ambiguity using a typing resolution score.
|
Paunić V, Gragert L, Schneider J, Müller C, Maiers M
|
Hum Immunol 77(7):542-549
|
|
2016
|
Killer cell immunoglobulin-like receptor ligand matching and outcomes after unrelated cord blood transplantation acute myeloid leukemia.
|
Rocha V, Ruggeri A, Spellman S, Wang T, Sobecks R, Locatelli F, Askar M, Michel G, Arcese W, Iori AP, Purtill D, Danby R, Sanz GF, Gluckman E, Eapen M
|
Biol Blood Marrow Transplant 22(7):1284-1289
|
|
2016
|
Donor and recipient sex in allogeneic stem cell transplantation: what really matters.
|
Kim HT, Zhang M-J, Woolfrey AE, St, Martin A, Chen J, Saber W, Perales M-A, Armand P, Eapen M
|
Haematologica
|
|
2016
|
Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study.
|
D'Souza A, Pasquini M, Logan B, Giralt S, Krishnan A, Antin J, Howard A, Goodman S, Qazilbash M, Knust K, Sahebi F, Weisdorf D, Vesole D, Vesole D, Stadtmauer E, Maloney D, Parameswaran H
|
Br J Haematol
|
|
2016
|
A comparative reference study for the validation of HLA-matching algorithms in the search for allogeneic hematopoietic stem cell donors and cord blood units.
|
Bochtler W, Gragert L, Patel ZI, Robinson J, Steiner D, Hofmann JA, Pingel J, Baouz A, Melis A, Schneider J, Eberhard H-P, Oudshoorn M, Marsh SGE, Maiers M, Müller CR
|
HLA 87(6):439-448
|
|
2016
|
Recovery of unrelated donors of peripheral blood stem cells versus recovery of unrelated donors of bone marrow: a prespecified analysis from the phase III Blood and Marrow Transplant Clinical Trials Network protocol 0201.
|
Burns LJ, Logan BR, Chitphakdithai P, Miller JP, Drexler R, Spellman S, Switzer GE, Wingard JR, Anasetti C, Confer DL
|
Biol Blood Marrow Transplant 22(6):1108-16
|
|
2016
|
Scoring system prognostic of outcome in patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome.
|
Shaffer BC, Ahn KW, Hu Z-H, Nishihori T, Malone AK, Valcárcel D, Grunwald MR, Bacher U, Hamilton B, Kharfan-Dabaja MA, Saad A, Cutler C, Warlick E, Reshef R, Wirk BM, Sabloff M, Fasan O, Gerds A, Marks D, Olsson R, Wood WA, Costa LJ, Miller AM, Cortes J, Daly A, Kindwall-Keller TL, Kamble RT, Rizzieri DA, Cahn J-Y, Gale RP, William B, Litzow M, Wiernik PH, Liesveld J, Savani BN, Vij R, Ustun C, Copelan E, Popat U, Kalaycio M, Maziarz R, Alyea E, Sobecks R, Pavletic S, Tallman M, Saber W
|
J Clin Oncol 34(16):1864-1871
|
|
2016
|
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children (<18y) and Young adults (18-29y) with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis
|
Chaudhury S, Sparapani R, Hu ZH, Nishihori T, Abdel-Azim H, Malone A, Olsson R, Hamadani M, Daly A, Bacher U, Wirk BM, Kamble RT, Gale RP, Wood WA, Hale G, Wiernik PH, Hashmi SK, Marks DI, Ustun C, Munker R, Savani BN, Alyea E, Popat U, Sobecks R, Kalaycio M, Maziarz R, Hijiya N, Saber W
|
Biol Blood Marrow Transplant 22(6):1056-1064
|
|
2016
|
Allogeneic hematopoietic cell transplantation for patients with mixed phenotype acute leukemia
|
Munker R, Brazauskas R, Wang HL, de Lima M, Khoury HJ, Gale RP, Maziarz RT, Sandmaier BM, Weisdorf D, Saber W
|
Biol Blood Marrow Transplant 22(6):1024-1029
|
|
2016
|
Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey.
|
Niederwieser D, Baldomero H, Szer J, Gratwohl M, Aljurf M, Atsuta Y, Bouzas LF, Confer D, Greinix H, Horowitz M, Iida M, Lipton J, Mohty M, Novitzky N, Nunez J, Passweg J, Pasquini MC, Kodera Y, Apperley J, Seber A, Gratwohl A
|
Bone Marrow Transplant 51(6):778-785
|
|
2016
|
Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: A report from the Center for International Blood and Marrow Transplant Research.
|
Lazaryan A, Wang T, Spellman SR, Wang H-L, Pidala J, Nishihori T, Askar M, Olsson R, Oudshoorn M, Abdel-Azim H, Yong A, Gandhi M, Dandoy C, Savani B, Hale G, Page K, Bitan M, Reshef R, Drobyski W, Marsh SGE, Schultz K, Müller CR, Fernandez-Viña M, Verneris MR, Horowitz MM, Arora M, Weisdorf DJ, Lee SJ
|
Haematologica
|
|
2016
|
Unrelated donor search prognostic score to support early HLA consultation and clinical decisions.
|
Wadsworth K, Albrecht M, Fonstad R, Spellman S, Maiers M, Dehn J
|
Bone Marrow Transplant
|
|
2016
|
Identification of high-risk amino-acid substitutions in hematopoietic cell transplantation: a challenging task.
|
Marino SR, Lee SM, Binkowski TA, Wang T, Haagenson M, Wang H-L, Maiers M, Spellman S, van Besien K, Lee SJ, Karrison T, Artz A
|
Bone Marrow Transplant
|
|
2016
|
Changing trends of unrelated umbilical cord blood transplantation (UCBT) for hematological diseases in patients older than 50 years: an Eurocord - CIBMTR survey.
|
Rafii H, Ruggeri A, Volt F, Brunstein CG, Carreras J, Eapen M, Gluckman E, Weisdorf DJ
|
Biol Blood Marrow Transplant
|
|
2016
|
Early cytomegalovirus reactivation remains associated with increased transplant related mortality in the current era: a CIBMTR analysis.
|
Teira P, Battiwalla M, Ramanathan M, Barrett AJ, Ahn KW, Chen M, Green JS, Saad A, Antin JH, Savani BN, Lazarus HM, Seftel M, Saber W, Marks D, Aljurf M, Norkin M, Wingard JR, Lindemans CA, Boeckh M, Riches ML, Auletta JJ
|
Blood 127(20):2427-2438
|
|
2016
|
Administrative claims data for economic analyses in hematopoietic cell transplantation: challenges and opportunities
|
Preussler JM, Mau, LW, Majhail NS, Meyer CL, Denzen E, Edsall KC, Farnia SH, Silver A, Saber W, Burns LJ, Vanness DJ
|
Biol Blood Marrow Transplant
|
|
2016
|
Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTN.
|
Shaw BE, Lee SJ, Horowitz MM, Wood WA, Rizzo JD, Flynn KE
|
Bone Marrow Transplant
|
|
2016
|
Diversity in Exon 5 of HLA-C∗04:01:01G is significant in anthropological studies.
|
Dunn PPJ, Lamb G, Selwyn C, Compton J, Yang E, Maiers M, Fernandez-Vina M
|
Hum Immunol 77(5):426-428
|
|
2016
|
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and survival free of progression and GVHD (GRFS).
|
Van Besien K, Hari P, Zhang M-J, Liu H-T, Stock W, Godley L, Odenike O, Larson R, Bishop M, Wickrema A, Gergis U, Mayer S, Shore T, Tsai S, Rhodes J, Cushing MM, Korman S, Artz A
|
Haematologica 101(5):634-643
|
|
2016
|
Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions.
|
Kumar R, Kimura F, Ahn KW, Hu Z-H, Kuwatsuka Y, Klein JP, Pasquini M, Miyamura K, Kato K, Yoshimi A, Inamoto Y, Ichinohe T, Wood WA Jr, Wirk B, Seftel M, Rowlings P, Marks DI, Schultz KR, Gupta V, Dedeken L, George B, Cahn J-Y, Szer J, Lee JW, Ho AY, Fasth A, Hahn T, Khera N, Dalal J, Bonfim C, Aljurf M, Atsuta Y, Saber W
|
Biol Blood Marrow Transplant 22(5):932-940
|
|
2016
|
Harvests from bone marrow donors who weigh less than their recipients are associated with a significantly increased probability of a suboptimal harvest yield.
|
Anthias C, Billen A, Arkwright R, Szydlo RM, Madrigal JA, Shaw BE
|
Transfusion 56(5):1052-1057
|
|
2016
|
Safety of ruxolitinib therapy prior to allogeneic hematopoietic stem-cell transplantation for myeloproliferative neoplasms.
|
Hanif A, Hari PN, Atallah E, Carlson K-SB, Pasquini MC, Michaelis LC
|
Bone Marrow Transplant 51(4):617-618
|
|
2016
|
7/8 and 9/10 or better high resolution match rate for the Be The Match® Unrelated Donor Registry.
|
Buck K, Wadsworth K, Setterholm M, Maiers M, Confer D, Hartzman R, Schmidt A, Yang SY, Dehn J
|
Biol Blood Marrow Transplant 22(4):759-763
|
|
2016
|
The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis.
|
Williams KM, Ahn KW, Chen M, Aljurf MD, Agwu AL, Chen AR, Walsh TJ, Szabolcs P, Boeckh MJ, Auletta JJ, Lindemans CA, Zanis-Neto J, Malvezzi M, Lister J, de Toledo Codina JS, Sackey K, Chakrabarty JLH, Ljungman P, Wingard JR, Seftel MD, Seo S, Hale GA, Wirk B, Smith MS, Savani BN, Lazarus HM, Marks DI, Ustun C, Abdel-Azim H, Dvorak CC, Szer J, Storek J, Yong A, Riches MR
|
Bone Marrow Transplant 51(4):573-580
|
|
2016
|
GVHD after HLA-matched sibling BMT or PBSCT: comparison of North American Caucasian and Japanese populations.
|
Kanda J, Brazauskas R, Hu ZH, Kuwatsuka Y, Nagafuji K, Kanamori H, Kanda Y, Miyamura K, Murata M, Fukuda T, Sakamaki H, Kimura F, Seo S, Aljurf M, Yoshimi A, Milone G, Wood WA, Ustun C, Hashmi S, Pasquini M, Bonfim C, Dalal J, Hahn T, Atsuta Y, Saber W
|
Biol Blood Marrow Transplant 22(4):744-751
|
|
2016
|
Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium - Haplo2014, San Francisco, California, December 4, 2014.
|
Al Malki MM, Horowitz M, Handgretinger R, Leung W, Roy D-C, Huang X-J, Fuchs E, Locatelli F, Blaise D, Mineishi S, Martelli M, Miller J, June C, Ai H-S, Luznik L, Mavilio D, Lugli E, van den Brink MRM, Champlin RE, Ciurea SO
|
Biol Blood Marrow Transplant 22(4):594-604
|
|
2016
|
New light chain amyloid response criteria help risk stratification of patients by day 100 after autologous hematopoietic cell transplant.
|
D'Souza A, Huang J, Hari P
|
Biol Blood Marrow Transplant 22(4):768-770
|
|
2016
|
A proportional hazards regression model for the subdistribution with covariates-adjusted censoring weight for competing risks data.
|
He P, Eriksson F, Scheike TH, Zhang M-J
|
Scand Stat Theory Appl 43(1):103-122
|
|
2016
|
Patient housing barriers to hematopoietic cell transplantation: results from a mixed-methods study of transplant center social workers.
|
Preussler JM, Mau L-W, Majhail NS, Bevans M, Clancy E, Messner C, Parran L, Pederson KA, Ferguson SS, Walters K, Murphy EA, Denzen EM
|
Support Care Cancer 24(3):1167-1174
|
|
2016
|
Significant improvements in the practice patterns of adult related donor care in US transplantation centers.
|
Anthias C, Shaw BE, Kiefer DM, Liesveld JL, Yared J, Kamble RT, D'Souza A, Hematti P, Seftel MD, Norkin M, DeFilipp Z, Kasow KA, Abidi MH, Savani BN, Shah NN, Anderlini P, Diaz MA, Malone AK, Halter JP, Lazarus HM, Logan BR, Switzer GE, Pulsipher MA, Confer DL, O'Donnell PV
|
Biol Blood Marrow Transplant 22(3):520-527
|
|
2016
|
Observational studies: matching or regression?
|
Brazauskas R, Logan BR
|
Biol Blood Marrow Transplant 22(3):557-563
|
|
2016
|
Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission.
|
Seftel MD, Neuberg D, Zhang M-J, Wang H-L, Ballen KK, Bergeron J, Couban S, Freytes CO, Hamadani M, Kharfan-Dabaja MA, Lazarus HM, Nishihori T, Paulson K, Saber W, Sallan SE, Soiffer R, Tallman MS, Woolfrey AE, DeAngelo DJ, Weisdorf DJ
|
Am J Hematol 91(3):322-329
|
|
2016
|
European Group for Blood and Marrow Transplantation centers with FACT-JACIE accreditation have significantly better compliance with related donor care standards.
|
Anthias C, O'Donnell PV, Kiefer DM, Yared J, Norkin M, Anderlini P, Savani BN, Diaz MA, Bitan M, Halter JP, Logan BR, Switzer GE, Pulsipher MA, Confer DL, Shaw BE
|
Biol Blood Marrow Transplant 22(3):514-519
|
|
2016
|
The GL service: web service to exchange GL string encoded HLA & KIR genotypes with complete and accurate allele and genotype ambiguity.
|
Milius RP, Heuer M, George M, Pollack J, Hollenbach JA, Mack SJ, Maiers M
|
Hum Immunol 77(3):249-256
|
|
2016
|
Asymmetric linkage disequilibrium: tools for assessing multiallelic LD.
|
Single RM, Strayer N, Thomson G, Paunic V, Albrecht M, Maiers M
|
Hum Immunol 77(3):288-294
|
|
2016
|
On modeling Human Leukocyte antigen-identical sibling match probability for allogeneic hematopoietic cell transplantation: estimating the need for an unrelated donor source.
|
Besse K, Maiers M, Confer D, Albrecht M
|
Biol Blood Marrow Transplant 22(3):410-417
|
|
2016
|
Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application.
|
Torikai H, Mi T, Gragert L, Maiers M, Najjar A, Ang S, Maiti S, Dai J, Switzer KC, Huls H, Dulay GP, Reik A, Rebar EJ, Holmes MC, Gregory PD, Champlin RE, Shpall EJ, Cooper LJN
|
Sci Rep 6:21757
|
|
2016
|
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors.
|
Kanate AS, Mussetti A, Kharfan-Dabaja MA, Ahn KW, DiGilio A, Beitinjaneh A, Chhabra S, Fenske TS, Freytes C, Gale RP, Ganguly S, Hertzberg M, Klyuchnikov E, Lazarus HM, Olsson R, Perales M-A, Rezvani A, Riches M, Saad A, Slavin S, Smith SM, Sureda A, Yared J, Ciurea S, Armand P, Salit R, Bolaños-Meade J, Hamadani M
|
Blood 127(7):938-947
|
|
2016
|
Hematopoietic cell transplantation outcomes in monosomal karyotype myeloid malignancies.
|
Pasquini MC, Zhang M-J, Medeiros BC, Armand P, Hu Z-H, Nishihori T, Aljurf MD, Akpek G, Cahn J-Y, Cairo MS, Cerny J, Copelan EA, Deol A, Freytes CO, Gale RP, Ganguly S, George B, Gupta V, Hale GA, Kamble RT, Klumpp TR, Lazarus HM, Luger SM, Liesveld JL, Litzow MR, Marks DI, Martino R, Norkin M, Olsson RF, Oran B, Pawarode A, Pulsipher MA, Ramanathan M, Reshef R, Saad AA, Saber W, Savani BN, Schouten HC, Ringdén O, Tallman MS, Uy GL, Wood WA Jr, Wirk B, Pérez WS, Batiwalla M, Weisdorf DJ
|
Biol Blood Marrow Transplant 22(2):248-257
|
|
2016
|
Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis.
|
Riches ML, Trifilio S, Chen M, Ahn KW, Langston A, Lazarus HM, Marks DI, Martino R, Maziarz RT, Papanicolou GA, Wingard JR, Young J-AH, Bennett CL
|
Bone Marrow Transplant 51(2):277-282
|
|
2016
|
Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis.
|
Riches ML, Trifilio S, Chen M, Ahn KW, Langston A, Lazarus HM, Marks DI, Martino R, Maziarz RT, Papanicolou GA, Wingard JR, Young J-AH, Bennett CL
|
Bone Marrow Transplant
|
|
2016
|
Infections following transplantation of bone marrow or peripheral-blood stem cells from unrelated donors.
|
Young JAH, Logan BR, Wu J, Wingard JR, Weisdorf DJ, Mudrick C, Knust K, Horowitz MM, Confer DL, Dubberke ER, Pergam SA, Marty FM, Strasfeld LM, Brown JM, Langston AA, Schuster MG, Kaul DR, Martin SI, Anasetti C
|
Biol Blood Marrow Transplant 22(2):359-370
|
|
2016
|
Characteristics and outcomes of aplastic anemia in HIV patients: a brief report from the severe aplastic anemia working party of the European Society of Blood and Bone Marrow Transplantation.
|
Pagliuca S, Gérard L, Kulasekararaj A, Eapen M, Boutboul D, Martin H, Salvino MA, Knol-Bout C, Dufour C, Peffault de Latour R, Marsh J
|
Bone Marrow Transplant 51(2):313-315
|
|
2016
|
DAS181 treatment of severe parainfluenza virus 3 pneumonia in allogeneic hematopoietic stem cell transplant recipients requiring mechanical ventilation.
|
Dhakal B, D'Souza A, Pasquini M, Saber W, Fenske TS, Moss RB, Drobyski WR, Hari P, Abidi MZ
|
Case Rep Med 2016:8503275
|
|
2016
|
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.
|
Kollman C, Spellman SR, Zhang M-J, Hassebroek A, Anasetti C, Antin JH, Champlin RE, Confer DL, DiPersio JF, Fernandez-Viña M, Hartzman RJ, Horowitz MM, Hurley CK, Karanes C, Maiers M, Mueller CR, Perales M-A, Setterholm M, Woolfrey AE, Yu N, Eapen M
|
Blood 127(2):260-267
|
|
2016
|
Global use of peripheral blood vs bone marrow as source of stem cells for allogeneic transplantation in patients with bone marrow failure.
|
Yoshimi A, Baldomero H, Horowitz M, Szer J, Niederwieser D, Gratwohl A, Kodera Y
|
JAMA 315(2):198-200
|
|
2016
|
Low socioeconomic status, adverse gene expression profiles, and clinical outcomes in hematopoietic stem cell transplant recipients.
|
Knight JM, Rizzo JD, Logan BR, Wang T, Arevalo JMG, Ma J, Cole SW
|
Clin Cancer Res 22(1):69-78
|
|
2016
|
Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma.
|
Klyuchnikov E, Bacher U, Woo Ahn K, Carreras J, Kröger NM, Hari PN, Ku GH, Ayala E, Chen AI, Chen Y-B, Cohen JB, Freytes CO, Gale RP, Kamble RT, Kharfan-Dabaja MA, Lazarus HM, Martino R, Mussetti A, Savani BN, Schouten HC, Usmani SZ, Wiernik PH, Wirk B, Smith SM, Sureda A, Hamadani M
|
Bone Marrow Transplant 51(1):58-66
|
|
2016
|
Presensitization to HY antigens in female donors prior to transplant is not associated with male recipient post-transplant HY antibody development nor with clinical outcomes.
|
Nakasone H, Sahaf B, Tian L, Wang T, Haagenson MD, Schoenrock K, Perloff S, Ryan CE, Wu F, Spellman SR, Lee SJ, Ritz J, Miklos DB
|
Haematologica 101(1):e30-e33
|
|
2016
|
Determination of eligibility in related pediatric hematopoietic cell donors: ethical and clinical considerations. Recommendations from a working group of the Worldwide Network for Blood and Marrow Transplantation Association.
|
Bitan M, van Walraven SM, Worel N, Ball LM, Styczynski J, Torrabadella M, Witt V, Shaw BE, Seber A, Yabe H, Greinix HT, Peters C, Gluckman E, Rocha V, Halter J, Pulsipher MA
|
Biol Blood Marrow Transplant 22(1):96-103
|
|
2016
|
Survival of patients who develop solid tumors following hematopoietic stem cell transplantation.
|
Ehrhardt MJ, Brazauskas R, He W, Rizzo JD, Shaw BE
|
Bone Marrow Transplant 51(1):83-88
|
|
2016
|
Analysis of a genetic plymorphism in the costimulatory molecule TNFSF4 with hematopoietic stem cell transplant outcomes.
|
Jindra PT, Conway SE, Ricklefs SM, Porcella SF, Anzick SL, Haagenson M, Wang T, Spellman S, Milford E, Kraft P, McDermott DH, Abdi R
|
Biol Blood Marrow Transplant 22(1):27-36
|
|
2016
|
Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).
|
Wood WA, Le Rademacher J, Syrjala KL, Jim H, Jacobsen PB, Knight JM, Abidi MH, Wingard JR, Majhail NS, Geller NL, Rizzo JD, Fei M, Wu J, Horowitz MM, Lee SJ
|
Cancer 122(1):91-98
|
|
|